Aethlon medical announces fiscal year end financial results and provides corporate update

Conference call to be held today at 4:30pm et san diego , june 28, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal year ended march 31, 2023 and provided an update on recent developments.  company updates aethlon medical is continuing the research and clinical development of its hemopurifier®, a therapeutic blood filtration system that can bind and remove harmful exosomes and life-threatening viruses from blood.
AEMD Ratings Summary
AEMD Quant Ranking